Adjuvant chemotherapy for epithelial ovarian cancer (EOC)

被引:0
|
作者
Kumar, Lalit [1 ]
Prasad, Roopa Hari [1 ]
Sengar, Manju [1 ]
机构
[1] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4 / 5
页数:2
相关论文
共 50 条
  • [31] STAGE-I EPITHELIAL OVARIAN-CANCER - ADJUVANT CHEMOTHERAPY AND PROGNOSTIC FACTORS
    KAWAI, M
    KIKKAWA, F
    MIZUNO, K
    KOJIMA, M
    ISHIKAWA, H
    TAMAKOSHI, K
    SUGANUMA, N
    NAKASHIMA, N
    HATTORI, S
    KUZUYA, K
    OHTA, M
    ARII, Y
    TOMODA, Y
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1994, 13 (01) : 77 - 81
  • [32] Completion of Adjuvant Chemotherapy and Use of Health Services for Older Women With Epithelial Ovarian Cancer
    Fairfield, Kathleen M.
    Murray, Kimberly
    Lucas, F. Lee
    Wierman, Heidi R.
    Earle, Craig C.
    Trimble, Edward L.
    Small, Laurie
    Warren, Joan L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) : 3921 - 3926
  • [33] Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer
    Paris, Ida
    Cianci, Stefano
    Vizzielli, Giuseppe
    Fagotti, Anna
    Ferrandina, Gabriella
    Alletti, Salvatore Gueli
    Costantini, Barbara
    Cosentino, Francesco
    Capoluongo, Ettore
    Pasqualoni, Mariangela
    Scambia, Giovanni
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 35 (01) : 370 - 374
  • [34] Benefit of adjuvant chemotherapy for stage I epithelial ovarian cancer according to the histologic type
    Fujiwara, Hiroyuki
    Takei, Yuji
    Saga, Yasushi
    Machida, Shizuo
    Sato, Naoto
    Yoshida, Chikako
    Takahashi, Suzuyo
    Taneichi, Akiyo
    Suzuki, Mitsuaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study
    Seebacher, Veronika
    Reinthaller, Alexander
    Koelbl, Heinz
    Concin, Nicole
    Nehoda, Regina
    Polterauer, Stephan
    [J]. PLOS ONE, 2017, 12 (01):
  • [36] Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer
    Frielink, Lindy M. J.
    Pijlman, Brenda M.
    Ezendam, Nicole P. M.
    Pijnenborg, Johanna M. A.
    [J]. CHEMOTHERAPY, 2015, 61 (06) : 287 - 294
  • [37] Features and clinical outcomes for younger women with epithelial ovarian cancer (EOC)
    Colomba-Blameble, E.
    Pautier, P.
    Michels, J.
    Pommeret, F.
    Kfoury, M.
    Maulard, A.
    Gouy, S.
    Morice, P.
    Genestie, C.
    Leary, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S633 - S633
  • [38] Characterization of Oncogenesis Process of Sporadic and Familial Epithelial Ovarian Cancer (EOC)
    Kamieniak, M. M.
    Munoz-Repeto, I.
    Garcia-Donas, J.
    Robles, L.
    Ramon y Cajal, T.
    Cazorla, A.
    Hernandez, E. A.
    Palacios, J.
    Benitez, J.
    Garcia, M. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S146 - S147
  • [39] Intraperitoneal chemotherapy for epithelial ovarian cancer
    AlHayki, Maryam
    Hopkins, Laura
    Le, Tien
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2006, 61 (08) : 529 - 534
  • [40] CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER
    ATKINSON, RJ
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1985, 154 (11) : 441 - 441